Infant Phototherapy System
- UID
- IMP/MD/2023/001189_06bc40b46b376ae225dc563a9543dc80_76819d6b3463e586cf6ae95ae432e674
- Device class
- Class B
- Brand name
- Bilisoft 2.0 Phototherapy System
- License holder
- Wipro GE Healthcare Private Limited
- Approving authority
- CDSCO
- Product information
- The BiliSoft 2.0 Phototherapy System provides light therapy for the treatment of indirect hyperbilirubinemia, commonly known as neonatal jaundice, during the newborn period in a hospital or home setting. The BiliSoft 2.0 Phototherapy System emits a narrow band of blue light considered to be the most effective in the treatment of hyperbilirubinemia.
Infant Phototherapy System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/001189_06bc40b46b376ae225dc563a9543dc80_76819d6b3463e586cf6ae95ae432e674. This device is marketed under the brand name Bilisoft 2.0 Phototherapy System. The license holder is Wipro GE Healthcare Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.